Desensitization of neurotensin receptor-mediated cyclic GMP formation in neuroblastoma clone N1E-115
- PMID: 2840079
- DOI: 10.1016/0006-2952(88)90047-0
Desensitization of neurotensin receptor-mediated cyclic GMP formation in neuroblastoma clone N1E-115
Abstract
Murine neuroblastoma clone N1E-115 possesses receptors that specifically bind the tridecapeptide neurotensin, mediate the formation of intracellular cyclic GMP, and stimulate inositol phospholipid hydrolysis. These cells also rapidly degrade neurotensin in a sequential fashion. We studied the effect of prolonged exposure of cells to neurotensin on subsequent neurotensin receptor-mediated intracellular cyclic GMP formation under conditions that prevented degradation of this peptide [J. A. Gilbert and E. Richelson, Soc. Neurosci. Abstr. 12, 762 (1986)]. Neurotensin receptor-mediated cyclic GMP formation in neuroblastoma clone N1E-115 was decreased following prolonged exposure of intact cells to nondegraded neurotensin. The time course of this desensitization was very rapid; the maximal effect on cyclic GMP production (reduction to 10-30% of control values) occurred within 5 min of exposure of intact cells to neurotensin. This desensitization was homologous, as cells desensitized by neurotensin demonstrated no decrease in their cyclic GMP response to angiotensin II (1 microM) or bradykinin (10 nM). Neurotensin preincubation with intact N1E-115 cells for increasing lengths of time caused time-dependent shifts to the right of the dose-response curve and reductions in the maximum cyclic GMP response. Desensitization was reversible, but resensitization was a slower process than desensitization: full recovery of cyclic GMP production required incubation of the desensitized cells for at least 10 min at 37 degrees. From binding studies with [3H]neurotensin, we found that both the apparent equilibrium dissociation constant, KD, and the maximum number of receptor sites, Bmax, for this radioligand were decreased significantly (P less than 0.05) for completely desensitized cells from those values for control cells. These data suggest that desensitization of the neurotensin receptor involved an uncoupling of the pathway of events connecting receptor activation to intracellular cyclic GMP formation; complete desensitization involved both the apparent loss of neurotensin receptors on the cellular surface and the increase in affinity of the remaining receptors for the agonist. This decrease in Bmax is more likely to be a result of intracellular sequestration of recyclable NT receptors than of true down-regulation due to the rapid resensitization seen for the NT-mediated biological response.
Similar articles
-
Desensitization and down-regulation of neurotensin receptors in murine neuroblastoma clone N1E-115 by [D-Lys8] neurotensin(8-13).J Pharmacol Exp Ther. 1993 Jan;264(1):1-5. J Pharmacol Exp Ther. 1993. PMID: 8380855
-
Neurotensin and its analogs--correlation of specific binding with stimulation of cyclic GMP formation in neuroblastoma clone N1E-115.Biochem Pharmacol. 1986 Feb 1;35(3):391-7. doi: 10.1016/0006-2952(86)90210-8. Biochem Pharmacol. 1986. PMID: 2868725
-
Further characterization of neurotensin receptor desensitization and down-regulation in clone N1E-115 neuroblastoma cells.Biochem Pharmacol. 1993 May 25;45(10):2149-54. doi: 10.1016/0006-2952(93)90029-v. Biochem Pharmacol. 1993. PMID: 8390262
-
Regulation of neurotensin receptor expression and function in a neuronal model system.Ann N Y Acad Sci. 1992;668:120-8. doi: 10.1111/j.1749-6632.1992.tb27344.x. Ann N Y Acad Sci. 1992. PMID: 1334384 Review. No abstract available.
-
Maintaining cell sensitivity to G-protein coupled receptor agonists: neurotensin and the role of receptor gene activation.J Neuroendocrinol. 2001 May;13(5):473-9. doi: 10.1046/j.1365-2826.2001.00658.x. J Neuroendocrinol. 2001. PMID: 11328459 Review.
Cited by
-
Repeated effects of the neurotensin receptor agonist PD149163 in three animal tests of antipsychotic activity: assessing for tolerance and cross-tolerance to clozapine.Pharmacol Biochem Behav. 2015 Jan;128:78-88. doi: 10.1016/j.pbb.2014.11.015. Epub 2014 Nov 26. Pharmacol Biochem Behav. 2015. PMID: 25433325 Free PMC article.
-
Rational design of novel neurotensin mimetics: discovery of a pharmacologically unprecedented agent exhibiting concentration-dependent dual effects as antagonist and full agonist.J Comput Aided Mol Des. 1994 Aug;8(4):433-40. doi: 10.1007/BF00125377. J Comput Aided Mol Des. 1994. PMID: 7815094
-
The role of NTS2 in the development of tolerance to NT69L in mouse models for hypothermia and thermal analgesia.Behav Brain Res. 2011 Oct 31;224(2):344-9. doi: 10.1016/j.bbr.2011.06.014. Epub 2011 Jun 21. Behav Brain Res. 2011. PMID: 21718721 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials